Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation in Healthy Subjects

NCT03182413 is registered in ClinicalTrials.gov with Theranexus as lead sponsor.

NCT NCT03182413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03182413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation in Healthy Subjects
Lead sponsor
Theranexus
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2015
Completion date
March 31, 2016
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sleep deprivation